Open AccessImpact of Adjuvant Therapy on Survival in Curatively Resected Gallbladder Carcinoma
Author(s) -
Sunil Choudhary,
Anjana Asthana
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/15113.6436
Subject(s) - medicine , adjuvant therapy , radiation therapy , proportional hazards model , adjuvant , stage (stratigraphy) , gallbladder , gallbladder cancer , surgery , adverse effect , carcinoma , disease , adenocarcinoma , gastroenterology , oncology , chemotherapy , cancer , paleontology , biology
Gallbladder carcinoma (GBC) has the propensity to fail at loco-regional (LR) and distant sites despite aggressive radical surgery. Adjuvant therapy in the form of radiotherapy (RT), systemic chemotherapy (CT) and chemoradiation (CRT) is the usual practice. Due to rarity of this disease, there is limited evidence to suggest the type of adjuvant treatment which should be offered to the patients.